Peter Carlin sold $151k of ADNT
director at Adient plc. 7,843 shares at an average of $19.25, traded Sep 2, 2026, filed Sep 4, 2026.
Score components
- +15RoleDirector
- +11Trade size$151k at market
- +5Share of holdings soldSold 17% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001670541-26-000102, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | SOpen-market sale Ordinary Shares | -7,843 | $19.25 | $151k | 38,835 | 39 d ago |
Related signals
Other insiders at Adient plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | Adient plc | David Herberg EVP, EMEA | $16k 699 shares | -2% | |
| 46Moderate | Adient plc | Heather M Tiltmann EVP, CLO, CHRO & Secretary | $500k 22,000 shares | -17% | |
| 22Weak | ADNTsell Adient plc | Michel Pierre Rose Berthelin EVP, EMEA | $49k 2,500 shares | -2% | |
| 38Weak | ADNTsell Adient plc | Jerome J. Dorlack President and CEO | $273k 12,000 shares | -3% | |
| 33Weak | ADNTsell Adient plc | James Conklin EVP, Americas | $233k 11,500 shares | -18% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.